391 - Virologic Outcomes with Lenacapavir in Heavily Treatment-Experienced People with HIV: A Multi-Center Real-World Study

Presenting Author(s)

• 

  Christopher Kaperak, MD (he/him/his)

  Fellow
  University of Chicago Medicine
  Chicago, IL, United States

  Slides

Co-Author(s)

• YL

  Yijia Li, MD

  Clinical Assistant Professor
  University of Pittsburgh
  Pittsburgh, Pennsylvania, United States
• 

  Maria F. Sanes Guevara, MD (she/her/hers)

  Resident physician
  University of Pittsburgh
  Pittsburgh, PA, United States
• BS

  Beverly E. Sha, MD

  Division of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA
  Chicago, Illinois, United States
• SS

  Shivanjali Shankaran, MD

  Assistant Professor
  Rush University Medical Center
  Chicago, Illinois, United States
• MA

  Mariam Aziz, MD

  Associate Professor
  Rush University Medical Center
  Chicago, Illinois, United States
• NG

  Nancy Glick, MD

  Medical Director
  Sinai Infectious Disease Center
  Chicago, Illinois, United States
• 

  Bijou R. Hunt, MA

  Director
  Sinai Infectious Disease Center
  Chicago, Illinois, United States
• CC

  Cathy Creticos, MD

  Howard Brown Health
  Chicago, Illinois, United States
• PD

  Paul S. Djuricich, PharmD AAHIV

  Clinical Pharmacy Specialist
  University of Chicago Medicine
  Chicago, Illinois, United States
• AM

  Andrew Merker, PharmD

  Clinical Pharmacy Specialist
  UChicago Medicine
  Chicago, Illinois, United States
• 

  Aniruddha Hazra, MD (he/him/his)

  Associate Professor of Medicine
  University of Chicago
  Chicago, IL, United States